Product Name :
Zoliflodacin
Description:
Zoliflodacin (ETX0914;AZD0914) is a novel spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor. Zoliflodacin has potent in vitro antibacterial activity against Gram-positive and Gram-negative organisms, including S. aureus with the MIC90 of 0.25 μg/mL.
CAS:
1620458-09-4
Molecular Weight:
487.44
Formula:
C22H22FN5O7
Chemical Name:
(4’R,6’S,7’S)-17′-fluoro-4′,6′-dimethyl-13′-[(4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]-5′,15′-dioxa-2′,14′-diazaspiro[1,5-diazinane-3,8′-tetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadecane]-1′(10′),11′,13′,16′-tetraene-2,4,6-trione
Smiles :
C[C@H]1COC(=O)N1C1=NOC2=C(F)C3=C(CC4([C@H]5[C@H](C)O[C@H](C)CN35)C(=O)NC(=O)NC4=O)C=C21
InChiKey:
ZSWMIFNWDQEXDT-ZESJGQACSA-N
InChi :
InChI=1S/C22H22FN5O7/c1-8-7-33-21(32)28(8)17-12-4-11-5-22(18(29)24-20(31)25-19(22)30)16-10(3)34-9(2)6-27(16)14(11)13(23)15(12)35-26-17/h4,8-10,16H,5-7H2,1-3H3,(H2,24,25,29,30,31)/t8-,9+,10-,16+/m0/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Zoliflodacin (ETX0914;AZD0914) is a novel spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor. Zoliflodacin has potent in vitro antibacterial activity against Gram-positive and Gram-negative organisms, including S. aureus with the MIC90 of 0.25 μg/mL.|Product information|CAS Number: 1620458-09-4|Molecular Weight: 487.44|Formula: C22H22FN5O7|Chemical Name: (4’R,6’S,7’S)-17′-fluoro-4′,6′-dimethyl-13′-[(4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]-5′,15′-dioxa-2′,14′-diazaspiro[1,5-diazinane-3,8′-tetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadecane]-1′(10′),11′,13′,16′-tetraene-2,4,6-trione|Smiles: C[C@H]1COC(=O)N1C1=NOC2=C(F)C3=C(CC4([C@H]5[C@H](C)O[C@H](C)CN35)C(=O)NC(=O)NC4=O)C=C21|InChiKey: ZSWMIFNWDQEXDT-ZESJGQACSA-N|InChi: InChI=1S/C22H22FN5O7/c1-8-7-33-21(32)28(8)17-12-4-11-5-22(18(29)24-20(31)25-19(22)30)16-10(3)34-9(2)6-27(16)14(11)13(23)15(12)35-26-17/h4,8-10,16H,5-7H2,1-3H3,(H2,24,25,29,30,31)/t8-,9+,10-,16+/m0/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 140 mg/mL (287.Vunakizumab custom synthesis 21 mM; Need ultrasonic).|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Zoliflodacin has antibacterial activity against key Gram-positive (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus agalactiae), fastidious Gram-negative (Haemophilus influenzae, Neisseria gonorrhoeae), atypical (Legionella pneumophila), and anaerobic (Clostridium difficile) bacterial species, including isolates with known resistance to fluoroquinolones.SKF 81297 Technical Information The antibacterial activity of Zoliflodacin is shown to be via inhibition of DNA biosynthesis and accumulation of double-strand cleavages; this mechanism of action differs from those of other marketed antibacterial compounds, including fluoroquinolones.PMID:32639220 Zoliflodacin stabilizes and arrests the cleaved covalent complex of gyrase with double-strand broken DNA under permissive conditions and thus blocks religation of the double-strand cleaved DNA to form fused circular DNA.|Products are for research use only. Not for human use.|
